Oramed Pharmaceuticals Inc. — Director's Dealing 2012

Aug 9, 2012

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: ORAMED PHARMACEUTICALS INC. (ORMP.OB)
CIK: 0001176309
Period of Report: 2012-08-08

Reporting Person: KIDRON NADAV (Director, President and CEO, 10% Owner)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2012-08-08	Stock Option (right to buy)	$0.34	A	864000	Acquired	2022-08-08	Common Stock (864000)	Direct

Footnotes

F1: 252,000 of the Options shall vest immediately on August 8, 2012 and 36,000 Options shall vest on the last day of each month thereafter, commencing on August 31, 2012 and ending on December 31, 2013.